SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By | 2016-03-01T04:43:50+00:00 May 15th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

CLNT [Cleantech Solutions International,] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2012 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, DELAWARE 74-2235008 (State or other jurisdiction of (I.R.S. Employerorporation of organization) Identification No.) No. 9 Yanyu Middle Road Qianzhou Township, Huishan District, Wuxi City] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International,; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICERRBANES-OXLEY ACT OF 2002 I, Wanfen Xu, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International,; 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jianhua Wu ChiefExecutive Officer Wanfen Xu ChiefFinancial Officer (Principal Accounting Officer) CERTIFICATION f10q0312ex32i_cleantech.htm 4 EX-32.1]

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: CHINA YUCHAI INTERNATIONAL LIMITED To all Shareholders Meeting

[CHINA YUCHAI INTERNATIONAL LIMITED To all Shareholders Meeting CHINA YUCHAI INTERNATIONAL LIMITED Company NOTICE IS HEREBY GIVEN that the Annual General Meeting (the “ As Ordinary Business 1. To receive and adopt the audited financial statements and independent auditors’ report for the financial year ended December 31, 2011. 2. To approve an increase in the limit of the Directors’ fees] [EX-99.2 3 d352781dex992.htm EX-99.2]

By | 2016-03-02T22:49:01+00:00 May 15th, 2012|Categories: Chinese Stocks, CYD, Webplus ver|Tags: , , , , , |0 Comments

SFUN [SouFun] F-3:

[] [15 May 2012 Matter No. 877097 Doc Ref: WL/ot/1312068 Direct line: (852) 2842 9532 Email: wynne.lau@conyerdill.com SouFun Holdings Limited 8/F, T3, Xihuan Plaza 1 Xizhimenwai Avenue Xicheng District Beijing 100044 People’s Republic of China Dear Sirs, SouFun Holdings Limited (the “Company”) Re: Commission” Registration Statement” Securities Act” ADSs Class A Ordinary Shares Existing Sale Shares Class B Ordinary Shares Converted] [Consent of Independent Registered Public Accounting Firm Shenzhen, People’s Republic of China May 15, 2012 EX-23.1 3 d351135dex231.htm CONSENT OF ERNST & YOUNG HUA MING, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM]

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 6-K: SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman

[SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman Islands with limited liability) (Stock code: 981) Announcement Reference is made to the announcement of the Company dated 15 May 2012 regarding the proposed signing of the Cooperation Framework Agreement (the “ Unless otherwise specified, capitalized terms used herein shall have the same meanings as those defined in the Announcement. The Company]

By | 2016-03-08T19:28:12+00:00 May 15th, 2012|Categories: Chinese Stocks, SMI, Webplus ver|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 6-K: SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman

[SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION (Incorporated in the Cayman Islands with limited liability) (Stock code: 981) An official ceremony for the signing of the Cooperation Framework Document will be attended by, among others, Beijing officials and Mr. Zhang Wenyi, the Chairman of the Board of SMIC. BJEIT, BDAC and SMIC Beijing have agreed to negotiate in good faith with a view]

By | 2016-03-08T19:30:56+00:00 May 15th, 2012|Categories: Chinese Stocks, SMI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x March 31, 2012

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 5 EX-32.2]

By | 2016-02-07T15:49:19+00:00 May 15th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar